Why ApoB is the most important cardiovascular marker, what your numbers mean, and how peptide protocols interact with lipid metabolism.
Why ApoB Is The Marker That Matters LDL-C (the standard "bad cholesterol" number on most panels) is a calculated estimate. It misses a critical variable: particle number. Two people can have identical LDL-C values but wildly different cardiovascular risk — because risk is driven by how many LDL particles are in circulation, not how much cholesterol they're carrying. **ApoB (Apolipoprotein B)** measures particle number directly. Every atherogenic particle — LDL, VLDL, IDL, Lp(a) — carries exactly one ApoB molecule. ApoB count = atherogenic particle count. It's the most direct measure of cardiovascular risk available on a standard blood panel.
|------------|---------------|--------|
**LDL Particles (NMR):** >1,000 nmol/L is elevated; optimal <700 nmol/L for low-risk individuals, <500 nmol/L for high-risk.
Get these tested. Standard lipid panels don't include ApoB — you need to request it specifically (most labs include it for $25–50 extra, or via companies like Function Health or Boston Heart).
Coronary Artery Calcium (CAC) score via CT scan tells you whether ApoB has already caused damage. A CAC of 0 at age 45+ is powerfully reassuring — it means decades of particle exposure haven't resulted in measurable calcification. A CAC >100 indicates established disease requiring more aggressive intervention regardless of current ApoB.
Cost: $75–300 out of pocket. No contrast, low radiation, 10-minute procedure. Every peptide user with elevated ApoB should get one.
This is where it gets nuanced for peptide users:
**Tesamorelin** — FDA-approved specifically for reducing visceral adipose tissue (VAT). VAT is a major driver of dyslipidemia, particularly elevated triglycerides and small, dense LDL particles. Tesamorelin reduces VAT, which secondarily improves lipid profiles in many users. Expect triglycerides to improve; ApoB improvement is variable.
**Ipamorelin/CJC-1295** — GH elevations transiently increase lipolysis and FFA release. Short-term: may modestly raise LDL in some users. Long-term with visceral fat reduction: typically neutral to beneficial.
**BPC-157** — Direct anti-inflammatory effect may modestly improve lipid profile by reducing vascular inflammation. Not a primary lipid intervention.
**GHK-Cu** — Activates antioxidant pathways (SOD, catalase) that protect LDL particles from oxidation. Oxidized LDL is more atherogenic than native LDL; GHK-Cu's antioxidant activity may reduce this risk factor.
If your metabolic markers are clean (fasting glucose, HbA1c, insulin, triglycerides are optimal) but ApoB is still elevated, the drivers are likely:
1. **Saturated fat intake** — the most modifiable dietary driver
2. **Genetics (FH or polygenic)** — some people are genetically efficient at producing LDL particles regardless of lifestyle
3. **Thyroid function** — subclinical hypothyroidism raises LDL; always check TSH with a lipid panel
4. **Chronic stress/cortisol** — cortisol-mediated lipid metabolism can elevate ApoB
5. **Low estrogen (men)** — testosterone to estradiol conversion affects LDL receptor expression
**Lifestyle first:** Every 1g reduction in saturated fat per day lowers LDL-C approximately 1–2 mg/dL. Dietary change can move ApoB 10–20 mg/dL in motivated individuals.
**Omega-3s:** 3–4g EPA/DHA daily. Reduces triglycerides 20–30%, which also reduces particle number. Tracked in MyProtocolStack under nutrients — target serum omega-3 index 8–12%.
**Berberine:** 500 mg 2x/day has evidence for modest LDL reduction via PCSK9 inhibition.
**Statins:** For ApoB >130 with risk factors or established CAC, statins remain the most evidence-backed intervention. Discussion with a physician required.
ApoB is one of the key cardiovascular markers in MyProtocolStack's lab tracker. Enter your baseline, track it across draws, and StackAI will analyze trends — correlating your ApoB trajectory with your peptide protocol, omega-3 levels, inflammatory markers, and metabolic panel. The platform flags when ApoB moves in the wrong direction and surfaces possible causes based on your full panel.
Know your number. Track it. Act on it.
Enter your blood work in MyProtocolStack, run StackAI analysis, and get personalized insights based on your actual numbers — not generic charts.
Start Free →